Tesofensine: legal
This page summarises tesofensine's status in the places checked; it is not legal advice, and it does not cover every country or state.
United States
Tesofensine does not appear by name anywhere in the federal “Schedules of Controlled Substances”, read in full on 2026-11-19.[1] It is not an approved medicine in the United States. It was developed as a weight-loss drug: the best-known trial says “We undertook a phase II, randomised, double-blind, placebo-controlled trial in five Danish obesity management centres.”, and its authors concluded that “these findings of efficacy and safety need confirmation in phase III trials”.[2] PubMed links that paper to a later notice from the journal, an “Expression of concern in” The Lancet in 2013.[2] Not being federally scheduled is not the same as being legal to sell for consumption, and state law was not checked for this page.
Sport
The World Anti-Doping Agency's list, which states “This List shall come into effect on 1 January 2026.”, names “Tesofensine” among the “S6.B: SPECIFIED STIMULANTS”, a class marked “PROHIBITED IN-COMPETITION”.[3]
References
- 21 CFR part 1308, Schedules of Controlled Substances, full text as of 2026-11-13 (eCFR versioner, read 2026-11-19) — US Drug Enforcement Administration, via eCFR (National Archives)
- Astrup A et al., Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial, Lancet 2008 (PubMed record) — The Lancet, via PubMed (US National Library of Medicine)
- World Anti-Doping Code International Standard: Prohibited List 2026, Wayback capture of 19 November 2026 — World Anti-Doping Agency
Comments
Sign in to join the conversation.
No comments yet.